WT
CLB icon

Wilmington Trust’s Core Laboratories CLB Stock Holding History

Wilmington Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$207K Buy
1,236
+40
+3% +$7.12K ﹤0.01% 688
2014
Q1 		$237K Sell
1,196
-1,762
-60% -$333K ﹤0.01% 647
2013
Q4 		$565K Sell
2,958
-90
-3% -$16.7K 0.01% 484
2013
Q3 		$516K Sell
3,048
-1,349
-31% -$209K 0.01% 483
2013
Q2 		$666K Buy
+4,397
New +$623K 0.01% 415

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wilmington Trust's CLB Position: Q2 2014 in Review

Wilmington Trust increased its Core Laboratories (CLB) stake by 3.3% in Q2 2014, buying an estimated $7.12K and bringing the position to 1,236 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Wilmington Trust first reported a position in CLB in Q2 2013 and has held it in 5 quarters since. The position peaked at $666K in Q2 2013. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

  • Wilmington Trust held 1,236 shares of Core Laboratories worth $207K as of Q2 2014.
  • Wilmington Trust bought 40 Core Laboratories shares in Q2 2014, an estimated $7.12K.
  • Core Laboratories made up ﹤0.01% of Wilmington Trust's portfolio in Q2 2014, its #688 holding.
  • Wilmington Trust first reported a position in Core Laboratories in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust's Core Laboratories position peaked at $666K in Q2 2013.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.